JP2011528700A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011528700A5 JP2011528700A5 JP2011519181A JP2011519181A JP2011528700A5 JP 2011528700 A5 JP2011528700 A5 JP 2011528700A5 JP 2011519181 A JP2011519181 A JP 2011519181A JP 2011519181 A JP2011519181 A JP 2011519181A JP 2011528700 A5 JP2011528700 A5 JP 2011528700A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- penetration enhancer
- monoalcohol
- humectant
- breast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12986108P | 2008-07-24 | 2008-07-24 | |
| EP08305421A EP2147674A1 (en) | 2008-07-24 | 2008-07-24 | Transdermal pharmaceutical compositions comprising danazol |
| US61/129,861 | 2008-07-24 | ||
| EP08305421.3 | 2008-07-24 | ||
| PCT/EP2009/059538 WO2010010168A1 (en) | 2008-07-24 | 2009-07-24 | Transdermal pharmaceutical compositions comprising danazol |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011528700A JP2011528700A (ja) | 2011-11-24 |
| JP2011528700A5 true JP2011528700A5 (enExample) | 2012-09-06 |
| JP5667052B2 JP5667052B2 (ja) | 2015-02-12 |
Family
ID=39926759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011519181A Active JP5667052B2 (ja) | 2008-07-24 | 2009-07-24 | ダナゾールを含む経真皮医薬組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110118226A1 (enExample) |
| EP (2) | EP2147674A1 (enExample) |
| JP (1) | JP5667052B2 (enExample) |
| AU (1) | AU2009273211B2 (enExample) |
| CA (1) | CA2731501C (enExample) |
| ES (1) | ES2533854T3 (enExample) |
| WO (1) | WO2010010168A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10080760B2 (en) * | 2009-10-27 | 2018-09-25 | Besins Healthcare Luxembourg Sarl | Transdermal pharmaceutical compositions comprising active agents |
| US20180169117A1 (en) * | 2014-03-20 | 2018-06-21 | Otsuka Pharmaceutical Co., Ltd. | Pharmaceutical formulation comprising a substituted phenyl - (1,3-dihydro-isoindol-2-yl) - methanone |
| US10872313B2 (en) | 2015-06-02 | 2020-12-22 | ROCA Medical Ltd. | Method for repurposing NDC codes in a pharmaceutical database for venom derived allergens involved in venom immunotherapy |
| US10548974B2 (en) | 2015-06-02 | 2020-02-04 | ROCA Medical Ltd. | Therapeutic treatment kit for allergies based on DNA profiles |
| US10369215B2 (en) | 2015-06-02 | 2019-08-06 | ROCA Medical Ltd. | Predilution sets for distributing antigens |
| EP3934624B1 (en) * | 2019-12-09 | 2024-03-13 | Futura Medical Developments Limited | Topical composition and methods of measuring the cooling ability of a topical composition |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4007A (en) * | 1845-04-22 | Improvement in separating tannin and coloring-matter in quercitron-bark | ||
| US8015A (en) * | 1851-04-01 | Connecting and disconnecting wheels and axles | ||
| NL190146A (enExample) * | 1953-08-26 | |||
| DE3738620A1 (de) * | 1987-11-13 | 1989-05-24 | Luderschmidt Christoph | Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie |
| FR2718372B1 (fr) | 1994-04-08 | 1996-06-28 | Sofab | Dispensateur de produits fluides. |
| FR2723356B1 (fr) | 1994-08-08 | 1996-10-18 | Innovation Rech Plastique Sa | Dispositif de conditionnement d'un produit avec pompe manuelle de distribution en doses unitaires |
| FR2726810B1 (fr) | 1994-11-10 | 1997-01-31 | Soc D Promotion Rech Et Innova | Pompe doseuse a commande manuelle pour flacon a enveloppe deformable |
| AU5460800A (en) | 1999-06-02 | 2000-12-18 | Aviana Biopharm | Pharmaceutical transdermal compositions |
| US20040092494A9 (en) * | 2000-08-30 | 2004-05-13 | Dudley Robert E. | Method of increasing testosterone and related steroid concentrations in women |
| JP2004507511A (ja) * | 2000-08-30 | 2004-03-11 | ユニメッド・ファーマシューティカルズ・インコーポレーテッド | 女性におけるテストステロンおよび近縁ステロイド濃度を増大させる方法 |
| US20030003144A1 (en) * | 2001-05-01 | 2003-01-02 | Keller Brian C. | Sustained release formulations for nifedipine, dextromethorphan, and danazol |
| US20040072810A1 (en) * | 2001-11-07 | 2004-04-15 | Besins International Belgique | Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof |
| AU2006207868A1 (en) * | 2002-03-20 | 2006-09-28 | Alkermes, Inc. | Method and apparatus for producing dry particles |
| FR2848112B1 (fr) * | 2002-12-10 | 2007-02-16 | Besins Int Belgique | Composition pharmaceutique pour administration transdermique ou transmuqueuse comprenant au moins un progestatif et/ou au moins un oestrogene, son procede de preparation et ses utilisations |
| WO2004087123A1 (en) * | 2003-04-01 | 2004-10-14 | Laboratoires Besins International | Prevention and treatment of breast cancer with 4-hydroxy tamoxifen |
| MXPA05007266A (es) * | 2003-01-02 | 2006-01-17 | Femmepharma Holding Co Inc | Preparaciones farmaceuticas para tratamientos de enfermedades y trastornos del seno. |
| FR2851470B1 (fr) * | 2003-02-20 | 2007-11-16 | Besins Int Belgique | Composition pharmaceutique pour administration transdermique ou transmuqueuse |
| US7879357B2 (en) * | 2003-04-28 | 2011-02-01 | Bayer Schering Pharma Ag | Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients |
| US7132680B2 (en) * | 2003-06-09 | 2006-11-07 | International Business Machines Corporation | Organic field-effect transistor and method of making same based on polymerizable self-assembled monolayers |
| CA2433101A1 (en) * | 2003-06-23 | 2004-12-23 | Igor Gonda | Method of treatment of a female suffering from androgen insufficiency |
| PL1670433T3 (pl) * | 2003-10-10 | 2013-03-29 | Ferring Bv | Przezskórna formulacja farmaceutyczna do zmniejszania pozostałości na skórze |
| EP1634583A1 (en) * | 2004-09-09 | 2006-03-15 | Laboratoires Besins International | Testosterone gels comprising propylene glycol as penetration enhancer |
| NZ553446A (en) * | 2004-09-09 | 2010-05-28 | Besins Int Lab | Testosterone gels comprising propylene glycol as penetration enhancer |
| EP1647271A1 (en) * | 2004-10-14 | 2006-04-19 | Laboratoires Besins International | 4-Hydroxy tamoxifen gel formulations |
| US8067399B2 (en) * | 2005-05-27 | 2011-11-29 | Antares Pharma Ipl Ag | Method and apparatus for transdermal or transmucosal application of testosterone |
| WO2008059059A1 (en) * | 2006-11-17 | 2008-05-22 | Besins Healthcare | Pharmaceutical compositions comprising a bisphosphonate compound |
| CA2674078C (en) | 2006-12-26 | 2012-03-20 | Femmepharma Holding Company, Inc. | Topical administration of danazol |
| US10080760B2 (en) * | 2009-10-27 | 2018-09-25 | Besins Healthcare Luxembourg Sarl | Transdermal pharmaceutical compositions comprising active agents |
-
2008
- 2008-07-24 EP EP08305421A patent/EP2147674A1/en not_active Withdrawn
-
2009
- 2009-07-24 AU AU2009273211A patent/AU2009273211B2/en active Active
- 2009-07-24 JP JP2011519181A patent/JP5667052B2/ja active Active
- 2009-07-24 ES ES09800075.5T patent/ES2533854T3/es active Active
- 2009-07-24 WO PCT/EP2009/059538 patent/WO2010010168A1/en not_active Ceased
- 2009-07-24 EP EP09800075.5A patent/EP2303281B1/en active Active
- 2009-07-24 US US13/055,180 patent/US20110118226A1/en not_active Abandoned
- 2009-07-24 CA CA2731501A patent/CA2731501C/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6121561B2 (ja) | 組織再生のための組成物および方法 | |
| JP2009280627A5 (enExample) | ||
| JP2011528700A5 (enExample) | ||
| JP2010537988A5 (enExample) | ||
| JP2013511534A5 (enExample) | ||
| CN102218074B (zh) | 一种含有芍药苷和甘草次酸的透皮贴剂及其制备方法 | |
| CN102641299A (zh) | 一种痔疮外用药物组合物 | |
| WO2011127829A1 (zh) | 纳米碳颗粒作为治疗痔疮的外用药物的应用 | |
| CN101972225A (zh) | 一种含吡非尼酮的凝胶组合物 | |
| WO2016177269A1 (zh) | 一种治疗和/或预防男性型脱发的复方外用药 | |
| JP2018522875A (ja) | ジアセレインまたはレインの局所製剤およびその使用 | |
| TW201538156A (zh) | 小蘗鹼配方及其用途 | |
| ES2533854T3 (es) | Composiciones farmacéuticas transdérmicas que comprenden danazol | |
| CN101455654A (zh) | 精氨酸布洛芬凝胶剂及其制备方法 | |
| JP5643872B2 (ja) | 二酸化炭素経皮・経粘膜吸収用組成物 | |
| CN104138350A (zh) | 一种黄芩素温敏凝胶及其制备方法和应用 | |
| AU2024276277A1 (en) | Pharmaceutical composition | |
| CN102370947B (zh) | 具有消炎、止痒和消毒杀菌功效的外用制剂及其制备方法 | |
| CN102049050B (zh) | 抗疱疹病毒感染的药物组合物 | |
| ES2376865T3 (es) | Tratamiento y prevención de la cicatrización excesiva | |
| ES2272416T3 (es) | Preparaciones anhidras topicas para la piel. | |
| RU2586043C1 (ru) | Способ профилактики и лечения осложнений при лучевой терапии рака кожи | |
| JP5993336B2 (ja) | 二酸化炭素経皮・経粘膜吸収用組成物 | |
| CN105769859B (zh) | 一种治疗宫颈癌患者放疗后皮肤损伤的药物组合物及其应用 | |
| CN108434100A (zh) | 一种用于光动力疗法治疗鼻咽喉腔疾病的喷雾光敏剂组合物 |